BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30986207)

  • 1. Is there a fair allocation of healthcare research funds by the European Union?
    Kaló Z; van den Akker LHM; Vokó Z; Csanádi M; Pitter JG
    PLoS One; 2019; 14(4):e0207046. PubMed ID: 30986207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health research support through the European structural funds in central and eastern Europe and the Mediterranean.
    McCarthy M
    Health Res Policy Syst; 2012 Apr; 10():12. PubMed ID: 22480250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Challenge of Additionality: The Impact of Central Grants for Primary Healthcare on State-Level Spending on Primary Healthcare in India.
    Bowser DM; Jha R; Bhawalkar M; Berman P
    Int J Health Policy Manag; 2019 Jun; 8(6):329-336. PubMed ID: 31256565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden?
    Mitchell RJ; McClure RJ; Olivier J; Watson WL
    Med J Aust; 2009 Dec 7-21; 191(11-12):648-52. PubMed ID: 20028294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public health research systems in the European union.
    Conceição C; McCarthy M
    Health Res Policy Syst; 2011 Oct; 9():38. PubMed ID: 21970897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country size bias in global health: cross-country comparison of malaria policy and foreign aid.
    Jezek T
    Glob Health Res Policy; 2021 Feb; 6(1):4. PubMed ID: 33531079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical and health research: an analysis of country participation and research fields in the EU's Horizon 2020.
    Gallo F; Seniori Costantini A; Puglisi MT; Barton N
    Eur J Epidemiol; 2021 Dec; 36(12):1209-1217. PubMed ID: 33205246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral healthcare systems in the extended European union.
    Widström E; Eaton KA
    Oral Health Prev Dent; 2004; 2(3):155-94. PubMed ID: 15641621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Health Innovation and Research in Europe: introduction to the supplement.
    McCarthy M; Zeegers Paget D
    Eur J Public Health; 2013 Nov; 23 Suppl 2():2-5. PubMed ID: 24189788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference allocations and use of a disparity measure to inform the design of allocation funding formulas in public health programs.
    Buehler JW; Bernet PM; Ogden LL
    J Public Health Manag Pract; 2012; 18(4):333-8. PubMed ID: 22635187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European challenges of funding orphan medicinal products.
    Szegedi M; Zelei T; Arickx F; Bucsics A; Cohn-Zanchetta E; Fürst J; Kamusheva M; Kawalec P; Petrova G; Slaby J; Stawowczyk E; Vocelka M; Zechmeister-Koss I; Kaló Z; Molnár MJ
    Orphanet J Rare Dis; 2018 Nov; 13(1):184. PubMed ID: 30396361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misfinancing global health: a case for transparency in disbursements and decision making.
    Sridhar D; Batniji R
    Lancet; 2008 Sep; 372(9644):1185-91. PubMed ID: 18926279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allocation of labour to somatic and psychiatric specialist care--the effects of earmarked grants.
    Halsteinli V; Ose SO; Torvik H; Hagen TP
    Health Policy; 2006 Oct; 78(2-3):115-27. PubMed ID: 16472885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distributing Local Resources for Public Health Preparedness Grants: A Data-Driven Approach.
    Zamboni LM; Martin EG
    J Public Health Manag Pract; 2020; 26(4):349-356. PubMed ID: 30789592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Out-of-Pocket Health Spending in Countries With a Mediterranean Connection.
    Grima S; Spiteri JV; Jakovljevic M; Camilleri C; Buttigieg SC
    Front Public Health; 2018; 6():145. PubMed ID: 29876340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European Union funds and clinical toxicology].
    Wiszniewiecka M; Cejrowski D; Sein Anand J
    Przegl Lek; 2015; 72(9):491-2. PubMed ID: 26827576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.